Amber Tong

Stay informed with Amber Tong’s coverage and analysis for Fortune.

  • HONG KONG, CHINA – 2025/04/10: A Hong Kong and China flags seen next to the electronic board showing the price of the Hang Seng Index at Exchange Square. Asian markets rose on April 10, 2025, with the Hang Seng Index posting solid gains after Donald Trump announced a 90-day pause on tariffs targeting U.S. allies. The move came alongside a sharp increase on tariffs on Chinese goods, up to 125% increase. (Photo by May James/SOPA Images/LightRocket via Getty Images)Finance

    Top Chinese drugmaker Hengrui soars in Hong Kong trading debut

    By Amber Tong and Bloomberg
  • Passengers at Central station, operated by MTR Corp., in Hong Kong, China, on Tuesday, Feb. 28, 2023. Hong Kong will stop requiring masks to be worn in public places from Wednesday, drawing to a close the prolonged Covid era that damaged its economy and standing in the world. Photographer: Paul Yeung/Bloomberg via Getty ImagesEnvironment

    COVID-19 spikes in Hong Kong, Singapore as new wave spreads

    By Audrey Wan, Amber Tong, and others
  • SYDNEY, AUSTRALIA – NOVEMBER 17: Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents, on November 17, 2024 in Sydney, Australia. (Photo by Steve Christo – Corbis/Corbis via Getty Images)Health

    Novo Nordisk launches Wegovy in China with prices well below U.S.

    By Amber Tong and Bloomberg
  • A general view shows AstraZeneca signage on a building in Shanghai on September 5, 2024. Several employees of multinational pharmaceutical giant AstraZeneca are under investigation in China, the firm told AFP on September 5, after a report said they were being questioned about potentially illegal data collection and drug imports. (Photo by Hector RETAMAL / AFP) (Photo by HECTOR RETAMAL/AFP via Getty Images)Finance

    AstraZeneca’s drive for China dominance in focus as chief probed

    By Amber Tong and Bloomberg